Paul Ford - CEOMar 253 minSpecialty Drugs, Coronavirus, & the Opportunity to Reduce CostThe promise of a miracle drug to combat Corvid-19 like Hydroxychloroquine has created polarizing perspectives on the optimism of prescription innovation and ...
Paul Ford - CEOMar 251 minPodcast: OrchestraRx On "Reconstructing Healthcare" In this episode, Michael Menerey, host of the Reconstructing Healthcare podcast chats with Paul Ford, the Founder, and CEO of OrchestraRx. Join us as we disc...
Paul Ford - CEOMar 233 minTo Exclude or Not to Exclude?Excluding drugs from your formulary can save you money, but so can not excluding drugs. In working with Taft-Hartley Union Trust, employer groups, school dis...
Paul Ford - CEOMar 234 minImpact of Corvid-19 on Corporate Benefits: The Uphill Battle Just Got Steeper Learn about the 3 impacts to corporate benefits in the CORVID-19 age.